clan Posted - 53 minutes from now

@ItzaFugazi $MNKD I'll go with... ....saying "No!" to needles and nebulizers! Just inhale a puff! with Mannkind. $NVO $SNY $AMGN

grampslol Posted - 18 hours ago

$MNKD Cultists grasp onto delusions and ignore reality about decade old #afizzle the most rejected insulin by doctors and patients. A sad people. #dontblamephillymike #poorestsellingleasteffectivemostexpensive $LLY $NVO $SNY

clan Posted - 19 hours ago

$MNKD The metrics for Mannkind Corp. continue to improve and impress, now, and long into the future. 💎👐🏽 And no needles needed! 🚫💉 Just inhale. $LLY $NVO $SNY

clan Posted - 20 hours ago

$MNKD Mannkind Corp. revenues continue to grow. All hail Lasagna! $SNY $AMGN $BMY

EliSalas Posted - 22 hours ago

$PFE $SNY LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

Memphis_McCormick Posted - 22 hours ago

$PFE $SNY LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

TroyTiger Posted - 1 day ago

$TGTX suspiciously quiet... My gut says $SNY is preparing an offer.. Even if no offer yet, Briumvi is growing very well.. up is the only direction I can see here

gargoyl Posted - 1 day ago

$BLRX 👀” 🏃‍♀️ 🏃‍♂️ running ….. 🐎 ….. know what you own .. No to looser fear shorts Phil is the 🥷🏿 $SNY $CRSP $BLUE Long the 🦋

grampslol Posted - 2 days ago

Speaking of $SNY They're way ahead of $MNKD -201 for IPF Vicore ASPIREs To Be Major IPF Player As Sanofi Jumps Onboard----Uh-oh https://insights.citeline.com/SC150994/Vicore-ASPIREs-To-Be-Major-IPF-Player-As-Sanofi-Jumps-Onboard/

clan Posted - 2 days ago

Soon, $MNKD will be unteathered from the malcious restrictive acts of BP and corrupt funds and be allowed to continue its ascent skyward.🎈☁️ $LLY $NVO $SNY

swingingtech Posted - 2 days ago

$SNY $REGN $GILD $PFE https://wallstreetwaves.com/fda-approves-dupixents-re-submission-for-urticaria-by-sny-and-regn/

clan Posted - 2 days ago

Nice for $ELTP . More ups to come. 💎👐 $SNY $BMY $NVO

TroyTiger Posted - 2 days ago

$TGTX for those who think Roche $RHHBY can not buy TGTX due to antitrust that would be wrong IF they were going to replace Ocrevus with Brimuvi! Maybe they see that Briumvi is the better drug and could switch all current patients to Briumvi? Just a thought. Currently I do think $SNY is the more likely buyer... Either way, just a matter of time before some kind of sale/merger..

TroyTiger Posted - 2 days ago

$TGTX I had to buy a small amount more, anything under $30 is a good buy in. We will run again and rumors will be realized I believe. $BMY, $SNY , $PFE , $AZN must have interest.

clan Posted - 3 days ago

$MNKD News potentially on: Afrezza (peds, switch, India), and/or Tyvaso Teton, and/or clofazimine, and/or nintedanib, and/or debt pay down that could cause MNKD to move +$3.11/sh before year end? "So, what you are saying is, there's still a chance." 10B4YE $lly $sny $amgn

Diefreeandsell Posted - 3 days ago

@BixbyKnolls @arnolddiver @phuzzylodgik theres also $MRK $SNY $PFE $BMY $NVS . which one?

Logic102 Posted - 5 days ago

$SNY executives and scientists know Blarcamesine to be the next big thing in dementia treatment starting in Europe and they know former executive of Aventis and now CEO of $AVXL C. Missling well. With the RFK appointment they will Partner with AVXL

Benzinga Posted - 5 days ago

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease $REGN $SNY https://www.benzinga.com/general/biotech/24/11/42008174/fda-to-revisit-regeneron-sanofis-dupixent-for-rare-skin-disease

Diefreeandsell Posted - 5 days ago

$IBRX @phuzzylodgik Lots of BP in NJ area. Who could PSS be visiting here? When is that Jeffries London conf fireside chat? $SNY $JNJ $MRK $BMY

CedarPark Posted - 5 days ago

$TGTX adding more today, looking like Sanofi $SNY coud be the buyer we are looking for. They have the cash/stock deal ready... BUY.

DonCorleone77 Posted - 6 days ago

$REGN $SNY Regeneron, Sanofi announce FDA accepts Dupixent sBLA for review Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License Application, or sBLA, for Dupixent to treat adults and pediatric patients aged 12 years and older with chronic spontaneous urticaria, or CSU, whose disease is not adequately controlled with H1 antihistamine treatment. The target action date for the FDA decision is April 18, 2025. The resubmitted sBLA is supported by data from the multi-trial, LIBERTY-CUPID Phase 3 clinical program for Dupixent in CSU. The sBLA adds results from Study C, which was conducted in patients with uncontrolled CSU who were on standard-of-care antihistamines. Study C, the second LIBERTY-CUPID pivotal trial in biologic-naive patients, met its primary and key secondary endpoints confirming results seen in the previous Study A. Results showed Dupixent significantly reduced itch and urticaria activity. Safety results in all LIBERTY-CUPID Phase 3 trials were generally consistent with the known safety profile of Dupixent in its approved indications. Adverse events more commonly observed with Dupixent compared to placebo were injection site reactions and COVID-19 infection.

clan Posted - 6 days ago

$MNKD Flippers be warned: One day soon, MNKD w/b up $0.50/share at midday .... and will continue going up the rest of the day!↗️ So it is written -- so shall it be done. $LLY $SNY $PULM

Emma_King Posted - 1 week ago

💥 Huge news expected for MYNZ soon 💥 Nov 12: 51M volume, +28%, with 19M short volume. With everyone awaiting the meeting results, I have a strong feeling the r/s extension will be pushed out another 180 days. Mainz Biomed (MYNZ) has partnered with Thermo Fisher (TMO, $209.2B market cap, trading at ~$546.92) to develop a next-gen colorectal cancer screening tool for global markets. Thermo Fisher’s $42.4B revenue and advanced tech will boost MYNZ’s mRNA-based assays, achieving 85% detection for advanced adenomas, compared to competitors' 43% and 20%. With CRC cases up 500% in young people, MYNZ is leading early detection. Sentiment: Positive 1. Strategic partnership with industry giant Thermo Fisher 2. Access to Thermo Fisher's advanced tech 3. Potential for global commercialization 4. Development of home collection screening capability Win-win as TMO steps into the CRC market, too. Calling all apes, let’s crush the short sellers—this bull run is ours. $PFE $SNY

Avocado_smash Posted - 1 week ago

$MNOV Wait and hold until the company announce the detail of the settlement from $NVS $SNY, this is huge, imo. https://investors.medicinova.com/news-releases/news-release-details/medicinova-given-notice-monetary-damages-due-under-patent

clan Posted - 1 week ago

$MNKD Might these be the stats of a company that $AMGN $SNY or $LLY would find attractive? 💎👐🏼↗ For the good of all Mannkind. #AccretiveToEarnings

ripztrip Posted - 1 week ago

$NVAX $SNY $GILD Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to French drugmaker Sanofi. Shares of the U.S. biotech firm dropped about 8.2% to $8.28 in premarket trading. The U.S. vaccine maker now expects between $175 million and $225 million for full-year sales of its COVID vaccine, its only product on the market, down from the $275 million to $375 million it previously forecast.

StarLord13 Posted - 1 week ago

$NVAX I can’t believe Shah didn’t sell. $SNY down big on their investment here too 🤦‍♂️

Diefreeandsell Posted - 1 week ago

$IBRX @Crazyhorse6 and ahead of schedule for both UK and EU submissions! Now all we need is to partner for EU marketing of ANKTIVA. Who will it be $AZ $NVO $RHHBY $SNY ?

Giletjaune Posted - 1 week ago

$NVAX $MRNA $BNTX $SNY Why then be bullish???

SamLamp Posted - 1 week ago

$NVAX When Pfizer and Moderna are banned, there will be only one non-mRNA COVID vaccine left on the U.S. market—NOVAVAX. I’m buying today, this is my personal opinion. Moderna fall is clearly being driven by the trump win and RFK Jr.'s potential role in the new administration. $MRNA $BNTX $SNY